DBV Technologies SA (DBVT)
0.78
+0.02
(+2.47%)
USD |
NASDAQ |
Nov 04, 16:00
0.7831
0.00 (0.00%)
After-Hours: 20:00
DBV Technologies Enterprise Value: 9.250M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 9.250M |
| November 01, 2024 | 7.441M |
| October 31, 2024 | 9.096M |
| October 30, 2024 | 11.42M |
| October 29, 2024 | 13.10M |
| October 28, 2024 | 10.40M |
| October 25, 2024 | 17.57M |
| October 24, 2024 | 14.78M |
| October 23, 2024 | -0.3607M |
| October 22, 2024 | 1.554M |
| October 21, 2024 | 1.650M |
| October 18, 2024 | 2.044M |
| October 17, 2024 | 3.478M |
| October 16, 2024 | 1.554M |
| October 15, 2024 | -0.6974M |
| October 14, 2024 | 0.1876M |
| October 11, 2024 | 0.9351M |
| October 10, 2024 | 2.477M |
| October 09, 2024 | 2.035M |
| October 08, 2024 | 2.044M |
| October 07, 2024 | -0.3703M |
| October 04, 2024 | 1.554M |
| October 03, 2024 | -0.3703M |
| October 02, 2024 | -2.294M |
| October 01, 2024 | 4.440M |
| Date | Value |
|---|---|
| September 30, 2024 | 1.554M |
| September 27, 2024 | 1.170M |
| September 26, 2024 | 0.1209M |
| September 25, 2024 | 1.564M |
| September 24, 2024 | 4.451M |
| September 23, 2024 | 1.574M |
| September 20, 2024 | 5.894M |
| September 19, 2024 | 4.451M |
| September 18, 2024 | 2.526M |
| September 17, 2024 | 6.375M |
| September 16, 2024 | 6.375M |
| September 13, 2024 | 4.037M |
| September 12, 2024 | 4.932M |
| September 11, 2024 | 7.356M |
| September 10, 2024 | 7.347M |
| September 09, 2024 | 9.271M |
| September 06, 2024 | 11.20M |
| September 05, 2024 | 11.76M |
| September 04, 2024 | 13.21M |
| September 03, 2024 | 17.92M |
| August 30, 2024 | 20.81M |
| August 29, 2024 | 19.75M |
| August 28, 2024 | 18.02M |
| August 27, 2024 | 18.88M |
| August 26, 2024 | 20.81M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-100.94M
Minimum
Oct 28 2020
1.030B
Maximum
Jan 10 2020
206.33M
Average
109.56M
Median
Enterprise Value Benchmarks
| Edap TMS SA | 70.68M |
| Genfit SA | 288.04M |
| Cellectis SA | -52.07M |
| Adaptimmune Therapeutics PLC | 18.55M |
| Akari Therapeutics PLC | 25.86M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -33.12M |
| Total Expenses (Quarterly) | 33.84M |
| EPS Diluted (Quarterly) | -0.34 |
| Earnings Yield | -115.4% |